Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals - PubMed (original) (raw)
doi: 10.1172/JCI59011. Epub 2011 Dec 12.
Michelle Cazabat, Martine Dubois, Fatima-Ezzahra L'Faqihi, Mary Requena, Christophe Pasquier, Pascale Klopp, Jacques Amar, Laurent Alric, Karl Barange, Jean-Pierre Vinel, Bruno Marchou, Patrice Massip, Jacques Izopet, Pierre Delobel
Affiliations
- PMID: 22156200
- PMCID: PMC3248296
- DOI: 10.1172/JCI59011
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals
Maud Mavigner et al. J Clin Invest. 2012 Jan.
Abstract
Depletion of CD4+ T cells from the gut occurs rapidly during acute HIV-1 infection. This has been linked to systemic inflammation and disease progression as a result of translocation of microbial products from the gut lumen into the bloodstream. Combined antiretroviral therapy (cART) substantially restores CD4+ T cell numbers in peripheral blood, but the gut compartment remains largely depleted of such cells for poorly understood reasons. Here, we show that a lack of recruitment of CD4+ T cells to the gut could be involved in the incomplete mucosal immune reconstitution of cART-treated HIV-infected individuals. We investigated the trafficking of CD4+ T cells expressing the gut-homing receptors CCR9 and integrin α4β7 and found that many of these T cells remained in the circulation rather than repopulating the mucosa of the small intestine. This is likely because expression of the CCR9 ligand CCL25 was lower in the small intestine of HIV-infected individuals. The defective gut homing of CCR9+β7+ CD4+ T cells - a population that we found included most gut-homing Th17 cells, which have a critical role in mucosal immune defense - correlated with high plasma concentrations of markers of mucosal damage, microbial translocation, and systemic T cell activation. Our results thus describe alterations in CD4+ T cell homing to the gut that could prevent efficient mucosal immune reconstitution in HIV-infected individuals despite effective cART.
Figures
Figure 1. CD4+ T cell depletion and HIV-1 persistence in the gut mucosa of HIV-infected individuals despite sustained effective cART.
(A) Frequencies of CD4+ in CD3+ T cells in the peripheral blood (PB) and jejunum mucosa of HIV-infected individuals (n = 20) and uninfected individuals (n = 9). Percentages of cells were determined by flow cytometry. Horizontal lines indicate median values. Each symbol represents an individual. (B) Absolute numbers of CD4+ T cells per surface unit of jejunum mucosa in HIV-infected individuals (n = 20) and uninfected individuals (n = 9). Horizontal lines indicate median values. Each symbol represents an individual. Immunohistochemical detection of intestinal CD4+ T cells (brown staining) in a representative HIV-infected individual and an uninfected control are shown. Original magnification, ×100. (C) Correlation between the frequency of CD4+ in CD3+ T cells in peripheral blood and jejunum mucosa (n = 20 HIV-infected individuals, and n = 9 uninfected individuals). Percentages of cells were determined by flow cytometry. Each symbol represents an individual. (D) Paired HIV-1 DNA loads in CD4+ T cells of the peripheral blood and jejunum mucosa (n = 20). HIV-1 DNA was quantified by real-time PCR.
Figure 2. Distribution of CCR9+β7hi CD4+ T cells in the peripheral blood and jejunum compartments.
(A) Flow cytometry analysis of CCR9 and β7 on CD4+ T cells in the peripheral blood and jejunum mucosa of a representative HIV-infected individual and an uninfected control. Numbers indicate the percentage of gated cells. (B) Correlation between the frequency of CCR9+β7hi in CD4+ T cells in peripheral blood and jejunum mucosa of HIV-infected individuals (n = 20) and uninfected individuals (n = 9). Percentages of cells were determined by flow cytometry. Each symbol represents an individual. (C) Frequency of CCR9+β7hi in CD4+ T cells in the peripheral blood and jejunum mucosa of HIV-infected individuals (n = 20) and uninfected individuals (n = 9). Percentages of cells were determined by flow cytometry. Horizontal lines indicate median values. Each symbol represents an individual.
Figure 3. Alterations in the CCL25-CCR9 axis that drives the gut homing of CCR9+β7hi CD4+ T cells in HIV-infected individuals.
(A) CCL25 mRNA expression in the jejunum epithelial cells of HIV-infected individuals (n = 18) and uninfected individuals (n = 7). Horizontal lines indicate median values. CCL25 mRNA was quantified by real-time RT-PCR and normalized to GAPDH. (B) CCL25 chemokine expression in the jejunum mucosa of HIV-infected individuals (n = 19) and uninfected individuals (n = 9). Horizontal lines indicate median values. A representative HIV-infected individual and an uninfected control are shown. CCL25 chemokine (brown) was stained by immunohistochemistry and automatically quantified with NIS-element (Nikon). Original magnification, ×400. (C) Correlation between CCL25 mRNA expression and the frequency of CCR9+β7hi in CD4+ T cells in the jejunum mucosa (n = 18 HIV-infected individuals, and n = 7 uninfected individuals). (D) Correlation between CCL25 mRNA expression and the frequency of CCR9+β7hi in CD4+ T cells in the peripheral blood (n = 18 HIV-infected individuals, and n = 7 uninfected individuals). Throughout, each symbol represents an individual.
Figure 4. CCR9+β7hi CD4+ T cells include most gut-homing Th17 cells.
(A) Paired frequencies of CCR6+ cells in CCR9+β7hi and CCR9–β7hi CD4+ T cell subsets in the peripheral blood (n = 20 HIV-infected individuals, and n = 9 uninfected individuals). Percentages of cells were determined using flow cytometry. (B) Paired frequencies of IL-17–producing cells in CCR9+β7hi and CCR9–β7hi CD4+ T cell subsets in the peripheral blood (n = 5 HIV-infected individuals, and n = 5 uninfected individuals). Percentages of cells were determined by flow cytometry.
Figure 5. Correlation between defective homing of CCR9+β7hi CD4+ T cells to the gut and mucosal damage, microbial translocation, and systemic T cell activation.
(A) Concentrations of I-FABP, LPS, and sCD14 in HIV-infected individuals (n = 20 for I-FABP and sCD14 concentrations, and n = 19 for LPS concentrations) and uninfected individuals (n = 9). Plasma I-FABP and sCD14 concentrations were measured by ELISA. Plasma LPS was measured by the Limulus amoebocyte lysate assay. Horizontal lines indicate median values. (B) Correlation between the frequency of CCR9+β7hi in CD4+ T cells in the peripheral blood and the plasma concentrations of LPS (n = 19 HIV-infected individuals, and n = 9 uninfected individuals) and sCD14 (n = 20 HIV-infected individuals, and n = 9 uninfected individuals). (C) Correlation between the frequency of CCR9+β7hi in CD4+ T cells in the jejunum mucosa and the plasma concentrations of LPS (n = 19 HIV-infected individuals, and n = 9 uninfected individuals) and sCD14 (n = 20 HIV-infected individuals, and n = 9 uninfected individuals). (D) Correlation between CCL25 mRNA expression in the jejunum mucosa and the plasma concentrations of LPS (n = 17 HIV-infected individuals, and n = 7 uninfected individuals) and sCD14 (n = 18 HIV-infected individuals, and n = 7 uninfected individuals). (E) Correlation between the frequency of CCR9+β7hi in CD4+ T cells in the peripheral blood and the frequency of Ki67+ in CD4+ T cells in the peripheral blood (n = 20 HIV-infected individuals). (F) Correlation between CCL25 mRNA expression in jejunum epithelial cells and the frequency of Ki67+ in CD4+ T cells in peripheral blood (n = 18 HIV-infected individuals). Throughout, each symbol represents an individual.
Similar articles
- The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients.
Allers K, Puyskens A, Epple HJ, Schürmann D, Hofmann J, Moos V, Schneider T. Allers K, et al. Mucosal Immunol. 2016 Jan;9(1):265-74. doi: 10.1038/mi.2015.58. Epub 2015 Jul 1. Mucosal Immunol. 2016. PMID: 26129649 - Gut-homing Δ42PD1+Vδ2 T cells promote innate mucosal damage via TLR4 during acute HIV type 1 infection.
Cheung AKL, Kwok HY, Huang Y, Chen M, Mo Y, Wu X, Lam KS, Kong HK, Lau TCK, Zhou J, Li J, Cheng L, Kiat Lee B, Peng Q, Lu X, An M, Wang H, Shang H, Zhou B, Wu H, Xu A, Yuen KY, Chen Z. Cheung AKL, et al. Nat Microbiol. 2017 Oct;2(10):1389-1402. doi: 10.1038/s41564-017-0006-5. Epub 2017 Aug 14. Nat Microbiol. 2017. PMID: 28808299 - Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G, Baroncelli S, Micci L, Ceccarelli G, Andreotti M, Sharma P, Fanello G, Fiocca F, Cavallari EN, Giustini N, Mallano A, Galluzzo CM, Vella S, Mastroianni CM, Silvestri G, Paiardini M, Vullo V. d'Ettorre G, et al. PLoS One. 2014 Oct 23;9(10):e109791. doi: 10.1371/journal.pone.0109791. eCollection 2014. PLoS One. 2014. PMID: 25340778 Free PMC article. Clinical Trial. - Th17 cells, HIV and the gut mucosal barrier.
Dandekar S, George MD, Bäumler AJ. Dandekar S, et al. Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3. Curr Opin HIV AIDS. 2010. PMID: 20543596 Review. - Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
Costiniuk CT, Angel JB. Costiniuk CT, et al. Mucosal Immunol. 2012 Nov;5(6):596-604. doi: 10.1038/mi.2012.82. Epub 2012 Aug 29. Mucosal Immunol. 2012. PMID: 22929559 Review.
Cited by
- Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism.
Ni W, Ren L, Liao L, Li D, Luo Z, Zhu M, Liu Y, Xing H, Wang Z, Shao Y. Ni W, et al. Front Immunol. 2024 May 10;15:1378048. doi: 10.3389/fimmu.2024.1378048. eCollection 2024. Front Immunol. 2024. PMID: 38799426 Free PMC article. - Intestinal barrier functions in hematologic and oncologic diseases.
Haroun E, Kumar PA, Saba L, Kassab J, Ghimire K, Dutta D, Lim SH. Haroun E, et al. J Transl Med. 2023 Mar 31;21(1):233. doi: 10.1186/s12967-023-04091-w. J Transl Med. 2023. PMID: 37004099 Free PMC article. Review. - Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A, Shahriari M, Bordbar MR, Hedayati SB, Ziyaeyan M, Jamalidoust M, Kalani M, Heydari Marandi N. Amanati A, et al. J Med Case Rep. 2023 Feb 10;17(1):66. doi: 10.1186/s13256-022-03750-8. J Med Case Rep. 2023. PMID: 36765433 Free PMC article. - Cardiovascular Disease and Thrombosis in HIV Infection.
Perkins MV, Joseph SB, Dittmer DP, Mackman N. Perkins MV, et al. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):175-191. doi: 10.1161/ATVBAHA.122.318232. Epub 2022 Dec 1. Arterioscler Thromb Vasc Biol. 2023. PMID: 36453273 Free PMC article. Review. - Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients.
Xia P, Xing XD, Yang CX, Liao XJ, Liu FH, Huang HH, Zhang C, Song JW, Jiao YM, Shi M, Jiang TJ, Zhou CB, Wang XC, He Q, Zeng QL, Wang FS, Zhang JY. Xia P, et al. Mil Med Res. 2022 May 27;9(1):24. doi: 10.1186/s40779-022-00384-1. Mil Med Res. 2022. PMID: 35619176 Free PMC article.
References
- Kunkel EJ, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med. 2000;192(5):761–768. doi: 10.1084/jem.192.5.761. - DOI - PMC - PubMed
- Papadakis KA, et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol. 2000;165(9):5069–5076. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials